Your browser doesn't support javascript.
loading
The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia.
Anderson-Schmidt, Heike; Gade, Katrin; Malzahn, Dörthe; Papiol, Sergi; Budde, Monika; Heilbronner, Urs; Reich-Erkelenz, Daniela; Adorjan, Kristina; Kalman, Janos L; Senner, Fanny; Comes, Ashley L; Flatau, Laura; Gryaznova, Anna; Hake, Maria; Reitt, Markus; Schmauß, Max; Juckel, Georg; Reimer, Jens; Zimmermann, Jörg; Figge, Christian; Reininghaus, Eva; Anghelescu, Ion-George; Konrad, Carsten; Thiel, Andreas; von Hagen, Martin; Koller, Manfred; Stierl, Sebastian; Scherk, Harald; Spitzer, Carsten; Folkerts, Here; Becker, Thomas; Dietrich, Detlef E; Andlauer, Till F M; Degenhardt, Franziska; Nöthen, Markus M; Witt, Stephanie H; Rietschel, Marcella; Wiltfang, Jens; Falkai, Peter; Schulze, Thomas G.
Afiliação
  • Anderson-Schmidt H; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen 37075, Germany. Electronic address: heike.anderson-schmidt@med.uni-goettingen.de.
  • Gade K; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen 37075, Germany.
  • Malzahn D; Department of Genetic Epidemiology, University Medical Center Göttingen, Georg-August-University, Göttingen 37099, Germany.
  • Papiol S; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
  • Budde M; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
  • Heilbronner U; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
  • Reich-Erkelenz D; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
  • Adorjan K; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
  • Kalman JL; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany; International Max Planck Research School for Translational Psychiatry, Max Planck Instit
  • Senner F; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
  • Comes AL; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany; International Max Planck Research School for Translational Psychiatry, Max Planck Institute of Psychiatry, Munich 80804, Germany.
  • Flatau L; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
  • Gryaznova A; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
  • Hake M; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany.
  • Reitt M; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen 37075, Germany.
  • Schmauß M; Department of Psychiatry and Psychotherapy, Bezirkskrankenhaus Augsburg, Augsburg 86156, Germany.
  • Juckel G; Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum 44791, Germany.
  • Reimer J; Department of Psychiatry, Klinikum Bremen-Ost, Bremen 28325, Germany.
  • Zimmermann J; Department of Psychiatry, Klinikum Bremen-Ost, Bremen 28325, Germany; Karl-Jaspers Clinic, European Medical School Oldenburg-Groningen, Oldenburg 26160, Germany.
  • Figge C; Karl-Jaspers Clinic, European Medical School Oldenburg-Groningen, Oldenburg 26160, Germany.
  • Reininghaus E; Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for Bipolar Affective Disorder, Medical University of Graz, Graz 8036, Austria.
  • Anghelescu IG; Department of Psychiatry, Dr. Fontheim - Mental Health, Liebenburg 38704, Germany.
  • Konrad C; Department of Psychiatry and Psychotherapy, Agaplesion Diakonieklinikum, Rotenburg 27356, Germany.
  • Thiel A; Department of Psychiatry and Psychotherapy, Agaplesion Diakonieklinikum, Rotenburg 27356, Germany.
  • von Hagen M; Clinic for Psychiatry and Psychotherapy, Clinical Center Werra-Meißner, Eschwege 37269, Germany.
  • Koller M; Asklepios Specialized Hospital, Göttingen 37081, Germany.
  • Stierl S; Psychiatric Hospital Lüneburg, Lüneburg 21339, Germany.
  • Scherk H; AMEOS Clinical Center Osnabrück, Osnabrück 49088, Germany.
  • Spitzer C; ASKLEPIOS Specialized Hospital Tiefenbrunn, Rosdorf 37124, Germany.
  • Folkerts H; Department of Psychiatry, Psychotherapy and Psychosomatics, Clinical Center Wilhelmshaven, Wilhelmshaven 26389, Germany.
  • Becker T; Department of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, Günzburg 89312, Germany.
  • Dietrich DE; AMEOS Clinical Center Hildesheim, Hildesheim 31135, Germany; Center for Systems Neuroscience (ZSN), Hannover 30559, Germany.
  • Andlauer TFM; Department of Translational Psychiatry, Max Planck Institute of Psychiatry, Munich 80804, Germany.
  • Degenhardt F; Institute of Human Genetics, University of Bonn School of Medicine & University Hospital Bonn, Bonn 53127, Germany; Department of Genomics, Life & Brain Center, University of Bonn, Bonn 53127, Germany.
  • Nöthen MM; Institute of Human Genetics, University of Bonn School of Medicine & University Hospital Bonn, Bonn 53127, Germany; Department of Genomics, Life & Brain Center, University of Bonn, Bonn 53127, Germany.
  • Witt SH; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim 68159, Germany.
  • Rietschel M; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim 68159, Germany.
  • Wiltfang J; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen 37075, Germany; German Center for Neurodegenerative Diseases (DZNE), Göttingen 37075, Germany; iBiMED, Medical Sciences Department, University of Aveiro, Aveiro, Portugal.
  • Falkai P; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich 80336, Germany.
  • Schulze TG; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich 80336, Germany; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen 37075, Germany.
Schizophr Res ; 210: 255-261, 2019 08.
Article em En | MEDLINE | ID: mdl-30611655
BACKGROUND: Religious delusions are a common symptom in patients experiencing psychosis, with varying prevalence rates of religious delusions across cultures and societies. To enhance our knowledge of this distinct psychotic feature, we investigated the mutually-adjusted association of genetic and environmental factors with occurrence of religious delusions. METHODS: We studied 262 adult German patients with schizophrenia or schizoaffective disorder. Association with lifetime occurrence of religious delusions was tested by multiple logistic regression for the following putative predictors: self-reported degree of religious activity, DSM-IV diagnosis, sex, age, education level, marital status, presence of acute delusion at the time of interview and an individual polygenic schizophrenia-risk score (SZ-PRS, available in 239 subjects). RESULTS: Of the 262 patients, 101 (39%) had experienced religious delusions. The risk of experiencing religious delusions was significantly increased in patients with strong religious activity compared to patients without religious affiliation (OR = 3.6, p = 0.010). Low or moderate religious activity had no significant effect. The same analysis including the SZ-PRS confirmed the effect of high religious activity on occurrence of religious delusions (OR = 4.1, p = 0.008). Additionally, the risk of experiencing religious delusions increased with higher SZ-PRS (OR 1.4, p = 0.020, using pT = 0.05 for SZ-PRS calculation). None of the other variables were significantly associated with lifetime occurrence of religious delusions. CONCLUSIONS: Our results suggest that strong religious activity and high SZ-PRS are independent risk factors for the occurrence of religious delusions in schizophrenia and schizoaffective disorder.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Religião e Psicologia / Esquizofrenia / Delusões Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Religião e Psicologia / Esquizofrenia / Delusões Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2019 Tipo de documento: Article